5.6 Transplant Rejection, Corneal

Date of last review:

5/9/2026

Date of next review:

5/9/2028

Date of publication:

16/9/2026


Differential diagnosis (1)  

  • Graft failure (transplant decompensation) – typically occurs without inflammation  

  • Suture‑related infection  

  • Infective keratitis  

  • Anterior uveitis   


Possible management by optometrist (1)

Advice (1)  

  • Emphasise that this is a potentially sight‑threatening emergency requiring immediate assessment  

  • Instruct the patient to attend the local Hospital Eye Service (HES) or A&E the same day  

  • Contact the receiving department to:   

    • Inform them of the referral  

    • Ensure the patient is expected and prioritised  

  • Where possible, communicate directly with a clinician or appropriate healthcare professional   

Treatment  (1)

  • No optometric treatment — emergency referral required  


Typical dosage/duration 

(Blue text = IP, black text = non-IP)

  • Not applicable for this condition (7) 


Further management options (1)

  • Emergency referral to ophthalmology – no intervention  

  • Immediate escalation is required to reduce the risk of graft failure and permanent visual loss   


Possible management in secondary care or local/community pathways where available (1)

  • Intensive topical corticosteroid therapy 

  • Systemic corticosteroids in more severe cases 

  • Additional systemic and/or topical immunosuppressive agents (e.g. ciclosporin, tacrolimus) 

  • Topical antiviral therapy if there is a history of herpes simplex infection 

  • Hospital admission where indicated 


College of Optometrists Clinical Management Guideline (1)  

Corneal transplant rejection - College of Optometrists  *

* With special thanks to The College of Optometrists for providing the evidence framework for diagnosis and management from the Clinical Management Guidelines (CMGs) for this condition. All references to the College/CMGs are included where appropriate and form the basis of the Community Eyecare Guidelines.


Guidance is informed by the following sources 

  1. College of Optometrists Clinical Management Guidelines Clinical Management Guidelines - College of Optometrists

  2. Advisory alignment with the College of Optometrists Formulary Optometrists' Formulary - College of Optometrists

  3. Advisory alignment with the BNF BNF (British National Formulary) | NICE

  4. Advisory alignment with the Summary Product Characteristics taken from the EMC Home - electronic medicines compendium (emc)

  5. Advisory alignment with Scottish Health Board formularies (where a clear majority is present) *

  6. Advisory alignment with expert consensus (CEGG), informed by sources 2-5 above

  7. Advisory alignment with expert consensus (CEGG) 

  8. “Annex C of the Statement” https://www.eyes.nhs.scot/for-professionals/legislation/

* Scottish formularies should be available within the Prescribing section of your Health Board pages on the eyes.nhs.scot website. If unavailable, contact your local Health Board for further information; Health Boards landing page 


If you have a query relating to this page, please email NSS.ComEyecareGuidelineGroup@nhs.scot